Sign in
Taking people in United StatesNo phase

Studies hip cup placement in hip replacement surgery using navigation

Tests a navigation system guiding hip cup placement in adults needing hip replacement.

Key facts

Who runs it
DePuy Orthopaedics
Where
Gainesville and Gastonia, United StatesSee the 2 sites
Trial code
Registry title
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
Status
Recruiting
People taking part
118 people, planned
Started
24 Oct 2025
Expected to end
31 Dec 2027
Type of study
Interventional
Treatments tested
  • EMPHASYS Cup with VHN
Record updated
4 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults 21 or older who are having a first hip replacement with an EMPHASYS cup, placed using the VELYS Hip Navigation system.

Age
21 years or older
Sex
All sexes can join
Disease stage
Hip problems such as osteoarthritis, traumatic arthritis, rheumatoid arthritis, hip dysplasia present from birth, or avascular necrosis of the femoral head, needing a first (primary) hip replacement.
Earlier treatment
No previous partial hip replacement in the affected hip. The other hip must not have been replaced less than 6 months before surgery.

Main reasons for not taking part

  • Active infection, local or in the whole body
  • Poor bone quality, such as osteoporosis, in the surgeon's opinion
  • Pregnant or breastfeeding
  • Taking part in a drug or device trial in the last three months
  • Less than 2 years of life expected

The registry criteria, word for word

Show all 21 criteriaShow less

Who can take part

  • All hip replacement component devices are to be used according to the approved indications
  • The subject is undergoing a standard of care primary uncemented hip replacement with the EMPHASYS cup and a CORAIL, EMPHASYS or ACTIS stem via the posterolateral, anterolateral, or direct lateral approach with the subject in the lateral decubitus position
  • The subject is a candidate for implantation utilizing the VELYS Hip Navigation system with CUPTIMIZE advanced
  • Individuals who are able to speak, read, and comprehend the Informed Participant Consent Document and willing and able to provide consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes
  • Individuals who are willing and able to complete follow-up as specified by the study protocol
  • Individuals who are willing and able to complete the Subject Hip Outcomes questionnaires (i.e., FJS-12, EQ-5D-5L and Hip Evaluation) as specified by the study protocol
  • Individuals who are not bedridden per the discretion of the investigator
  • Individuals who are a minimum age of 21 years at the time of consent

Who cannot take part

  • Poor bone quality, such as osteoporosis, where, in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the implant(s)
  • Previous partial hip replacement in affected hip
  • Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three months
  • Contralateral hip was replaced less than 6 months prior to surgery date
  • Active local or systemic infection
  • Charcot's or Paget's disease
  • Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia
  • Subject has a medical condition with less than 2 years of life expectancy
  • Subject, in the opinion of the Investigator, is a drug or alcohol abuser or has a psychological disorder that could affect their ability to complete subject reported questionnaires or be compliant with follow-up requirements
  • Loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified
  • The Subject is a woman who is pregnant or lactating
  • Subject had a contralateral amputation
  • Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims

Where in United States

  • Florida Orthopaedic InstituteGainesville, United StatesContact: Samantha FlamandTaking people
  • Carolina Orthopaedic and Sports Medicine CenterGastonia, United StatesContact: Samantha FlamandTaking people

About the trial

What the trial wants to find out

The purpose of this research is to gather clinical and radiographic (X-ray) information about EMPHASYS™ acetabular shell (also called a hip 'cup') placement in total hip replacement surgery using a non-invasive surgical navigation system called VELYS™ hip navigation system with CUPTIMIZE™ Advanced Hip-Spine Analysis software.

Read full original descriptionShow less

Data collected in this study will be compared with data collected from implantations using different cup positioning instrumentation and techniques to assess performance.

The group in the trial

  • EMPHASYS Cup with VHNOther group

    EMPHASYS Cup with Non-Invasive Navigation

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty With Non-Invasive Navigation
Plain-language title
Studies hip cup placement in hip replacement surgery using navigationGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
4 November 2026